https://www.orthoworld.com
ORTHOWORLD
Anika Therapeutics’ 4Q17 and 2017 Orthobiologic Revenue
Anika Therapeutics posted 4Q17 orthobiologic revenue of US $25.1MM, +3.1% vs. 4Q16, and 2017 revenue of $93.8MM, +4.6% vs. 2016.
Empowering Orthopaedic Executives through Strategic Intelligence
Product Labels: Viscosupplement
Tags: Revenue Report